Clinical Drug Experience Knowledgebase

anlotinib (2 trials)

cisplatin (platinol) (7 trials)

etoposide (vepesid) (1 trial)

irinotecan (Camptosar) (2 trials)

pemetrexed (alimta) (4 trials)

bevacizumab (avastin) (2 trials)

camrelizumab (1 trial)

carboplatin (paraplatin) (5 trials)

docetaxel (taxotere) (1 trial)

erlotinib (tarceva) (3 trials)

gefitinib (iressa) (3 trials)

gemcitabine (gemzar) (3 trials)

icotinib (Conmana) (1 trial)

nedaplatin (1 trial)

paclitaxel (taxol) (3 trials)

vinorelbine (navelbine) (2 trials)

afatinib (gilotrif) (1 trial)

almonertinib (1 trial)

avitinib (1 trial)

azd3759 (1 trial)

chidamide (1 trial)

crizotinib (xalkori) (1 trial)

dacomitinib (vizimpro) (1 trial)

hlx10 (1 trial)

lorlatinib (lorbrena) (1 trial)

nimotuzumab (1 trial)

nivolumab (opdivo) (1 trial)

osimertinib (tagrisso) (2 trials)

pembrolizumab (keytruda) (1 trial)

pyrotinib (1 trial)

savolitinib (1 trial)

sintilimab (2 trials)

x-396 (1 trial)